MangoRx is a small men's telehealth company that connects male patients with licensed physicians through its website, where physicians can prescribe treatments for erectile dysfunction, hair loss, hormone therapy, and weight management. Patients complete an online consultation, and if prescribed, receive medications shipped directly to their door. All compounding and fulfillment is handled by Epiq Scripts, a pharmacy majority-owned by MangoRx's CEO, which serves as the company's exclusive pharmacy partner. MangoRx's core products are compounded sublingual rapid dissolve tablets — dissolving under the tongue rather than swallowing a pill — which the company argues enables faster absorption. Products include Mango ED (Sildenafil or Tadalafil with Oxytocin), Grow (Minoxidil and Finasteride for hair loss), Slim (Semaglutide for weight loss), and Mojo (Enclomiphene for hormone balance). MangoRx also sells Prime, an FDA-approved oral testosterone replacement therapy licensed from Marius Pharmaceuticals. None of the compounded products carry FDA approval. MangoRx charges customers directly — it does not bill insurance — and revenue is driven by patient acquisition and recurring subscription orders. The company bears fixed fees per physician consultation regardless of whether a prescription is issued, and pays Epiq Scripts fixed per-prescription fees. MangoRx also holds an early-stage respiratory illness patent portfolio and has announced plans for a Solana-focused digital asset treasury, though neither has generated revenue.